Operations and Supply Chain Management

Scaling up production: The Achilles heel of many manufacturers
By Clarkston Consulting
White paper
Many manufacturers sustain huge economic losses from inefficient scale-up of R&D to full-scale manufacturing. According to this white paper by Clarkston Consulting, performing design for manufacturability, failure mode analysis and failure mode and effect analysis on the development of new products can reduce these losses.

Cracking Japanese drug development: A view from the inside
By Fulcrum Pharma Developments
White paper
This white paper from Fulcrum Pharma Developments Inc. features an interview with Teruyoshi Okuda, president of Fulcrum Pharma Developments KK. The Japanese market has always been difficult to access from the West due to differences in culture, medical approaches and regulatory requirements, but by choosing the right people on the ground, Western companies can succeed.

The program management office
By Clarkston Consulting
White paper
This white paper from Clarkston Consulting explains how a program management office can support business objectives to deliver better products and services at lower prices, improve visibility into the sales pipeline, integrate systems and provide real-time reports.

Scorecards and dashboards: More than just technology
By Clarkston Consulting
White paper
Before implementing a scorecard or dashboard application, according to this white paper from Clarkston Consulting, executives should consider what information or metrics they require to provide the right focus on organization, success and business value.

HealthCast tactics: A blueprint for the future
By PricewaterhouseCoopers
White paper
For this 2002 report by PricewaterhouseCoopers, more than 65 health care thought leaders were interviewed. The survey found significant gaps in providers reporting quality and safety data, payers reducing unnecessary administrative costs, and understanding how patient data is shared.

Mea culpa by a big pharma CEO
By Pfizer Inc.
White paper
Dr. Peter Rost, vice president of marketing for Pfizer Inc., reviews A Call to Action, a book by his boss, Pfizer CEO Hank McKinnell, about the pharmaceutical industry.

HHS importation study draws the wrong conclusions
By Pfizer Inc.
White paper
The 2005 Health and Human Services (HHS) study on drug reimportation estimated that total savings from legalized commercial importation would only be one to two percent of total drug spending. This Pfizer Inc. white paper argues that it's much higher.

Life sciences trends and challenges: A technology perspective for 2004-2007
By Hewlett-Packard Co.
White paper
This white paper from HP outlines where technology in the life sciences industry is moving from 2004-2007 and how the industry is adapting to the increasingly quick pace of change.

Compliance versus competitive advantage
By Clarkston Consulting
White paper
This white paper by Clarkston Consulting describes how chief information officers can consider compliance from a strategic point of view, including addressing education, internal reviews, problem areas and audits.

Global pharma company specifies Honeywell for UK facility
By Honeywell Process Solutions
Case study
In this case study, Honeywell International Inc. provides an integrated enterprise management system to a global pharmaceutical company to reach its environmental monitoring and reporting requirement goals, resulting in cost reduction, energy efficiency and improved asset management.